Actively Recruiting
Evaluating a New Rapid PCR Test for Diagnosing Severe Infectious Corneal Infections and Its Effect on Treatment
Led by CHU de Reims · Updated on 2024-09-19
46
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a new rapid multiplex PCR system for diagnosing severe infectious keratitis, a serious eye infection that can cause blindness and often requires long hospital stays. The study compares this new PCR method to conventional diagnostic methods to see if it can identify the infection-causing pathogens faster and more accurately. This observational study aims to improve treatment decisions, reduce hospital time, and improve visual outcomes for patients. The study involves two groups of patients hospitalized with severe infectious keratitis. The before group includes patients who previously received standard microbiological diagnosis methods such as direct microscopic examination, cultures, and PCR tests for viruses and amoebas. The after group includes patients who will receive the same standard tests plus additional corneal swabbing tested with two different FilmArray PCR systems called ME and BCID. These rapid PCR tests can detect multiple pathogens within 75 minutes, potentially speeding up diagnosis and targeted treatment. Participants will undergo full eye exams, corneal scraping, and swabbing for both standard and FilmArray PCR testing. Researchers will measure how quickly treatment is changed to target the detected pathogen within two weeks as the primary outcome. Secondary outcomes include hospital stay length, vision improvement, treatment changes after pathogen detection, pathogen types, and costs related to diagnosis and care. The study will follow patients for up to 12 months to assess visual acuity and other outcomes, with the goal of improving care management for severe corneal infections.
CONDITIONS
Brief Title
Use of a New Method for the Microbiological Diagnosis of Severe Corneal Infection
Research Team
A
Alexandre DENOYER
T
Thomas Ferreira de Moura
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here